ÂÜÀòÂÒÂ×

Kellie Mellish is an experienced professional in business development and scientific research, currently serving as the Director of Business Development for Drug Substance at Cambrex since September 2023. Previously, Kellie held the position of Business Development Manager at Piramal Pharma Solutions from August 2020 to September 2023, and worked as an Inside Sales Executive at SGS from April 2019 to August 2020. Earlier in Kellie's career, a diverse range of roles at AMRI included Business Operations Manager, Business Operations Specialist, and Research Scientist II, demonstrating a strong foundation in both operations and scientific research. Kellie's experience also encompasses project management at The Wercs, Ltd., research at Curia, and R&D formulation at BASF focused on specialty chemicals for the semiconductor industry. Kellie holds a Bachelor of Science degree in Chemistry from Clarkson University.